BMS, J&J challenges to Medicare negotiations are thrown out
In another setback for the pharma industry, a US federal judge has rejected a bid to overturn the Medicare pricing negotiation brought by Bristol-Myers Squibb and Johnson
Innovation as Strategy: Enabling life sciences of the future
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
Deep Dive: Market Access 2024
In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna
How doctors are interacting with content in 10 data trends
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
Patient Centricity to Integration: Enhancing Cancer Outcomes
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
15th World Bispecific Summit 2024
Radically Optimize Bi, Tri & Multispecific Antibodies to Enhance Target Discovery, Mechanistic Diversity & Clinical Translation to Maximize the Therapeutic Index & Enhance Combi
2nd ADC Toxicity Summit 2024
Improving Prediction & Translation of ADC Toxicities to Drive More Tolerable ADCs Successfully Into & Through Clinical Development